Back to top
more

If you wish to go to ZacksFunds.com, click OK. If you do not, click Cancel.

Janus Global Life Sciences D Shs: (MF: JNGLX)

(MF) As of May 4, 2015 06:05 PM ET

 Add to portfolio

$60.22 USD

+0.46 (0.77%)

Zacks MF Rank : 1 - Strong Buy [?] 1        

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

General Information as of Mar 31, 2015

% Yield 0.00
% SEC Yield NA
% YTD Return (as of Mar 31, 2015) 13.19
Category Sector - Health
Peer HL LG

Zacks Premium Research for JNGLX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Zacks MF Rank [?] Strong Buy 1
MF Research Report

( = Change in last 30 days)

Zacks Mutual Fund #1 Ranked Funds

View the Zacks Mutual Fund Rank Guide

Portfolio Statistics

%Unrealized Gain YTD 25.95
Net Assets (Mil $) 3/31/2015 1,243.47
%Turnover 3/31/2015 52.00

Allocation

% of Portfolio
Large Growth 19.50
Large Value 0.00
Small Growth 11.10
Small Value 0.00
Foreign Stock 0.00
Emerging Market 0.00
Precious Metal 0.00
Intermediate Bond 10.83
Foreign Bond 22.18
High Yield Bond 0.00

Sector / Country Weightings

As of 3/31/2015 % of Portfolio
Health 56.17
Other 18.09
Services 9.54
Finance 5.82
Industrial Cyclical 5.09
Retail Trade 2.74
Technology 1.16
Non-Durable 0.94
Consumer Durables 0.45

Portfolio Holdings

Top Equity Holdings
(As of 12/31/2014)
% of Portfolio Value (Mil$)
JOHNSON & JOHNSON 2.79 98.13
BIOGEN IDEC INC 2.54 89.50
AMGEN INC 2.40 84.48
VALEANT PHARMACEUTICALS 2.15 75.74
CELGENE CORP 2.14 75.23
PHARMACYCLICS INC 2.00 70.41
AETNA INC 2.00 70.38
ROCHE HOLDING AG GENUSSS 1.92 67.67
MALLINCKRODT PLC 1.92 67.64

Stock Holding % of Net Assets

As Of 12/31/2014
Total Issues 95
Avg. P/E 29.05
Avg. P/Book 5.57
Avg. EPS Growth 12.65
Avg. Market Value (Mil $) 46,538

Risk

3 Year 5 Year 10 Year
Beta 0.78 0.79 0.76
Alpha 22.77 14.68 8.88
R Squared 0.35 0.54 0.58
Std. Dev. 12.72 13.90 14.93
Sharpe 2.99 2.02 1.00